ConductScience.org, home

Trial · NCT01665053

Outcomes17

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

TypeOutcomeTime framePopulationUnitsMeasured as
PRIMARYPercentage of Participants With Target Lesion Failure (TLF) at 12 Months12 monthsThe per protocol population was used for this analysis. Therefore the number of participants analyzed is not consistent with the numbers provided in participant flow module.percentage of participantsNUMBER
SECONDARYPercentage of Participants With Target Lesion Revascularization (TLR) at 12 Months.12 monthsIntent-to-Treat populationpercentage of participantsNUMBER
SECONDARYPercentage of Participants With Target Vessel Revascularization (TVR) at 12 Months.12 monthsIntent-to- Treatpercentage of participantsNUMBER
SECONDARYPercentage of Participants With Target Vessel Failure (TVF) at 12 Month.12 monthsIntent-to-treat analysispercentage of participantsNUMBER
SECONDARYPercentage of Participants With Myocardial Infarction at 12 Month.12 monthsIntent-to-treatpercentage of participantsNUMBER
SECONDARYPercentage of Participants With Cardiac Death at 12 Month.12 monthsIntent-to-treat populationpercentage of participantsNUMBER
SECONDARYPercentage of Participants With Non-Cardiac Death at 12 Month.12 monthsIntent-to-treat populationpercentage of participantsNUMBER
SECONDARYPercentage of Patients That Died at 12 Months.12 monthsIntent-to-treat populationpercentage of participantsNUMBER
SECONDARYPercentage of Patients With Cardiac Death or Myocardial Infarction (MI) at 12 Month.12 monthsIntent-to-treat populationpercentage of participantsNUMBER
SECONDARYPercentage of Participants Who Died or Had an Myocardial Infarction (MI) at 12 Month.12 monthsIntent-to-treat populationpercentage of participantsNUMBER
SECONDARYPercentage of Participants Who Died, Had an Myocardial Infarction (MI) or a Target Vessel Revascularization (TVR) at12 Month.12 monthsIntent-to-treat populationpercentage of participantsNUMBER
SECONDARYPercentage of Participants With a ARC (Academic Research Consortium) Stent Thrombosis Rate at 12 Month.12 monthsIntent-to-treat population.percentage of participantsNUMBER
SECONDARYPercentage of Patients With a Stroke at 12 Month.12 monthsIntent-to-Treat population.percentage of participantsNUMBER
SECONDARYPeriprocedural Technical Success Rate.Day 1 (periprocedure)
Intent-to-Treat analysis set. Promus Element Plus population: 838 subject analyzed with 1043 lesions treated with technical success achieved in 1011 lesions.~SYNERGY population: 846 subjects analyzed with 1059 lesions treated with technical success achieved in 1041 lesions.
percentage of lesionsNUMBER
SECONDARYPeriprocedural Clinical Procedural Success RateDay 1 (periprocedure)Intent-to-Treat populationpercentage of subjectsNUMBER
SECONDARYPercentage of Participants With a Target Lesion Failure (TLF) at 12 Month.12 monthIntent-to-Treat populationpercentage of participantsNUMBER
SECONDARYPercentage of Patients With Revascularization (=All Revascularizations) at 12 Month.12 MonthIntent to treat populationpercentage of patientsNUMBER

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01665053/outcomes